Hibiclens has been trusted by hospitals for over 40 years as a pre/post-operative antiseptic skin cleanser.
Protect yourself before and after surgery
When facing a surgery or procedure, there are many things you might be worried about; however, using Hibiclens can help give you one less worry. Hibiclens has been trusted by hospitals for more than 40 years, with patients frequently instructed to wash with Hibiclens antiseptic skin cleanser before surgery or other procedures to reduce the risk of infection.
Cleaning the skin with a CHG solution such as Hibiclens before surgery is considered one of the keys to preventing surgical site infections (SSIs)1 and has been shown to be more effective than other skin cleansing options like washing with plain soap and water.2 Here’s why:
- Fast-acting – begins killing germs on contact3
- Proven to significantly reduce C. difficile,4 MRSA and other infections5
- Long-lasting – binds to the skin, leaving a layer of protection that continues to kill germs for up to 24 hours after application6
- Gentle on your skin, and as simple and easy to use as any liquid soap7
- The more often you use Hibiclens, the better it works, with the antibacterial protection growing greater with repeated use8
- Septimus EJ, Schweizer ML. Decolonization in Prevention of Health Care-Associated Infections. Clinical Microbiology Reviews. 2016;29(2):201-222. Doi:10.1128/CMR.00049-15.
- Final Report 041101-201. Final Report 040907-150.
- Paulson, Daryl S. Persistent and Residual Antimicrobial Effects: Are They Important in the Clinical Setting? Infection Control Today 2005; Vol 9. No 4.
- Rupp, Mark E., et al. Hospital-Wide Chlorhexidine Patient Bathing Project. University of Nebraska Medical Center 2010. Poster presented at 2010 SHEA Annual Scientific Meeting.
- Climo, Michael W., et al. The Effect of Daily Bathing with Chlorhexidine on the Acquisition of Methicillin-resistant Staphylococcus, aureus, Vancomycin-resistant Enterococcus, and Healthcare-associated Bloodstream Infections: Results of a Quasi-experimental Multicenter Trial. Critical Care Medicine. 2009;37(6):1858-1865.
- MBT Study No. 582-106, Study Protocol # 522.214.171.124.12.
- Mölnlycke Health Care, Data on File. Study # R05-0225.
- Ferrara MS, Courson R. Paulson DS. Evaluation of Persistent Antimicrobial Effects of an Antimicrobial Formulation. Journal of Athletic Training. 2011;46(6):629-633.